Skip to main content
Log in

Isolation and bioactivities of three IL-1β N-terminal variants

  • Cytokines
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Three distinct N-terminal variants of rhIL-1β can be generated by expression of the IL-1β gene in E. coli; the naturally occurring Ala1 species, Met0-Ala1 and des-Ala1 proteins. Since most studies with rhIL-1β have used a mixture of two or more variants, we have evaluated their individual bioactivities. The variants were resolved by cation exchange HPLC. Bioactivity measurement on murine thymocytes gave a potency order of Ala1 > des-Ala1 > Met0-IL-1β. Analysis using human T-cells co-stimulated with PMA showed a potency order of Ala1 > des-Ala1 > Met0-IL-1β. Thus changes in the N-terminal amino acid of IL-1β changes the activity of the protein. Since murine and human T-cells respond similarly, the interactions between the N-terminus of rhIL-1β and their receptors probably occur through comparable mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Y. Kikumoto, Y.-M. Hong, T. Nishida, S. Nakai, Y. Masui and Y. Hirai,Purification and characterization of recombinant human interleukin-1β produced in Escherichia coli, Biochem. Biophys. Res. Commun.147, 321–351 (1987).

    Google Scholar 

  2. D. B. Carter, K. A. Curry, C.-S. C. Tomich, A. W. Yem, M. R. Deibel, D. E. Tracey, J. W. Paslay, J. B. Carter, N. Y. Theriault, P. K. Harris, I. M. Reardon, H. A. Zurcher-Neely, R. L. Heinrickson, L. L. Clancy, S. W. Muchmore, K. D. Watenpaugh and H. M. Einspahr,Proteins: Structure, Function and Genetics,3, 121–129 (1988).

    Google Scholar 

  3. S. R. Kronheim, M. A. Cantrell, M. C. Deeley, C. J. March, P. J. Glackin, D. M. Anderson, T. Hemenway, J. E. Merriam, D. Cosman and T. P. Hop,Purification and characterization of human interleukin-1 expressed in Escherichia coli, Biotechnology4, 1078–1082 (1986).

    Google Scholar 

  4. P. Wingfield, M. Payton, J. Tavernier, M. Barnes, A. Shaw, K. Rose, G. Simona, S. Demczuk, K. Williamson and J.-M. Dayer,Purification and characterization of human interleukin-1β expresed in recombinant Escherichia coli, Eur. J. Biochem.160, 491–497 (1986).

    Google Scholar 

  5. P. Wingfield, P. Graber, N. RaoMovva, A. M. Gronenborn and H. Robson MacDonald,N-terminal-methionylated interleukin-1β has reduced receptor-binding affinity. FEBS letters215, 160–164 (1987).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richard, K.A., Yem, A.W., Deibel, M.R. et al. Isolation and bioactivities of three IL-1β N-terminal variants. Agents and Actions 27, 268–270 (1989). https://doi.org/10.1007/BF01972793

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01972793

Keywords

Navigation